Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A with the Cartitude-1 Trial

被引：0

作者：

Kamboj, Ishita ^{[1
,2
]}

Chang, Darryl ^{[3
]}

Habib, Alma ^{[4
]}

Vegel, Andrew ^{[5
]}

Struble, Emily ^{[5
]}

Shaikh, Hira ^{[2
,5
]}

Strouse, Christopher ^{[2
,5
]}

Davis, James A. ^{[2
,6
]}

Rashid, Aliya ^{[2
,7
,8
]}

Graf, Kevin ^{[2
,9
]}

Green, Kimberly M. ^{[10
]}

Mushtaq, Muhammad Umair ^{[8
,11
]}

Mahmoudjafari, Zahra ^{[2
,8
]}

Hashmi, Hamza ^{[2
,6
,11
]}

Mcguirk, Joseph P. ^{[8
]}

Abdallah, Al-Ola ^{[2
,8
]}

Atrash, Shebli ^{[2
,12
]}

Khan, Abdullah Mohammad ^{[2
,4
]}

Ahmed, Nausheen ^{[2
,8
]}

机构：

[1] Univ Kansas Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Kansas City, MO USA

[2] US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA

[3] Wake Forest Univ, Levine Canc Inst, Sch Med, Atrium Hlth, Charlotte, NC USA

[4] Ohio State Univ, Div Hematol, Columbus, OH USA

[5] Univ Iowa Hosp, Div Hematol Oncol & Blood & Marrow Transplantat, Iowa City, IA USA

[6] Med Univ South Carolina, Hollings Canc Ctr, Dept Hematol Oncol, Charleston, SC USA

[7] Univ Kansas Med Ctr, Internal Med, Kansas City, KS USA

[8] Univ Kansas Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Kansas City, KS USA

[9] Med Univ South Carolina, Dept Hematol Oncol, Charleston, SC USA

[10] Med Univ South Carolina, Div Hematol Oncol, Charleston, SC USA

[11] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA

[12] Wake Forest Univ, Atrium Hlth, Sch Med, Levine Canc Inst,Dept Hematol Oncol & Blood Disord, Charlotte, NC USA

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-199187

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：24112 / 24113

页数：2

共 50 条

[1] Efficacy and Safety of Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 Subgroup Analysis
Jakubowiak, Andrzej
Usmani, Saad Z.
Berdeja, Jesus G.
Agha, Mounzer
Cohen, Adam D.
Hari, Parameswaran
Schecter, Jordan M.
Madduri, Deepu
Yeh, Tzu-Min
Olyslager, Yunsi
Banerjee, Arnob
Jackson, Carolyn C.
Allred, Alicia
Zudaire, Enrique
Deraedt, William
Zhou, Changwei
Geng, Dong
Pacaud, Lida
Lin, Yi
Martin, Thomas
Jagannath, Sundar
BLOOD, 2021, 138
[2] Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE-1 (phase 2) Japanese cohort
Ri, Masaki
Suzuki, Kenshi
Ishida, Tadao
Kuroda, Junya
Tsukamoto, Taku
Teshima, Takanori
Goto, Hideki
Jackson, Carolyn C.
Sun, Huabin
Pacaud, Lida
Fujikawa, Ei
Yeh, Tzu-Min
Hatayama, Tomoyoshi
Aida, Kensuke
Sunagawa, Yoshihiro
Iida, Shinsuke
CANCER SCIENCE, 2022, 113 (12) : 4267 - 4276
[3] CARTITUDE-1: Phase 1b/2 study of ciltacabtagene autoleucel in relapsed/Refractory multiple myeloma
Madduri, Deepu
Berdeja, Jesus
Usmani, Saad
Jakubowiak, Andrzej
Agha, Mounzer
Cohen, Adam
Stewart, A. Keith
Hari, Parameswaran
Htut, Myo
O'Donnell, Elizabeth
Munshi, Nikhil
Avigan, David
Deol, Abhinav
Lesokhin, Alexander
Singh, Indrajeet
Zudaire, Enrique
Yeh, Tzu-Min
Allred, Alicia
Olyslager, Yunsi
Banerjee, Arnob
Goldberg, Jenna
Schecter, Jordan
Jackson, Carolyn
Deraedt, William
Zhuang, Sen Hong
Infante, Jeffrey
Geng, Dong
Wu, Xiaoling
Carrasco-Alfonso, Marlene
Akram, Muhammad
Hossain, Farah
Rizvi, Syed
Fan, Frank
Jagannath, Sundar
Lin, Yi
Martin, Thomas
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 16 - 17
[4] Health-Related Quality of Life in the Cartitude-1 Study of Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma
Martin, Thomas, III
Lin, Yi
Agha, Mounzer
Cohen, Adam D.
Htut, Myo
Stewart, A. Keith
Hari, Parameswaran
Berdeja, Jesus G.
Madduri, Deepu
Usmani, Saad Z.
Yeh, Tzu-Min
Allred, Alicia J.
Olyslager, Yunsi
Banerjee, Arnob
Goldberg, Jenna D.
Schecter, Jordan M.
Jackson, Carolyn C.
Deraedt, William
Gries, Katharine S.
Fastenau, John
Wu, Xiaoling
Carrasco, Marlene J.
Akram, Muhammad
Hossain, Farah
Jakubowiak, Andrzej
Jagannath, Sundar
BLOOD, 2020, 136
[5] Plain language summary of the CARTITUDE-1 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma
Berdeja, Jesus G.
Cohen, Adam D.
Martin, Thomas
Madduri, Deepu
Pacaud, Lida
Jagannath, Sundar
FUTURE ONCOLOGY, 2023, 19 (18) : 1235 - 1247
[6] Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma
Martin, Tom
Usmani, Saad Z.
Schecter, Jordan M.
Vogel, Martin
Jackson, Carolyn C.
Deraedt, William
Tian, Hong
Yeh, Tzu-min
Banerjee, Arnob
Pacaud, Lida
Garrett, Ashraf
Haltner, Anja
Cameron, Chris
Van Sanden, Suzy
Diels, Joris
Valluri, Satish
Samjoo, Imtiaz A.
CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (10) : 1779 - 1788
[7] Patient Expectations and Perceptions of Treatment in CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma
Cohen, Adam D.
Hari, Parameswaran
Htut, Myo
Berdeja, Jesus G.
Madduri, Deepu
Usmani, Saad Z.
Allred, Alicia J.
Olyslager, Yunsi
Banerjee, Arnob
Goldberg, Jenna D.
Schecter, Jordan M.
Jackson, Carolyn C.
Gries, Katharine S.
Fastenau, John
Deraedt, William
Carrasco, Marlene J.
Akram, Muhammad
Hossain, Farah
Crawford, Sigrid
Morrison, Ross
Doward, Lynda
Jakubowiak, Andrzej
BLOOD, 2020, 136
[8] Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice
Delforge, Michel
Vekemans, Marie-Christiane
Depaus, Julien
Meuleman, Nathalie
Van de Velde, Ann
Vande Broek, Isabelle
Vandervennet, Sophie
Van Hoorenbeeck, Sandra
Moorkens, Evelien
Strens, Danielle
Diels, Joris
Ghilotti, Francesca
Haefliger, Benjamin
Dalhuisen, Sander
Deraedt, William
Anguille, Sebastien
HEMASPHERE, 2022, 6 (12):
[9] Comparison of outcomes with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 versus real-world standard of care (RW SOC) for patients (pts) with triple-class exposed relapsed/refractory multiple myeloma (RRMM).
Martin, Thomas G.
Krishnan, Amrita Y.
Yong, Kwee
Mehra, Katja Weisel Maneesha
Nair, Sandhya
Qi, Keqin
Londhe, Anil
Diels, Joris
Crivera, Concetta
Jackson, Carolyn Chang
Olyslager, Yunsi
Vogel, Martin
Schecter, Jordan Mark
Banerjee, Arnob
Valluri, Satish
Usmani, Saad Zafar
Berdeja, Jesus G.
Jagannath, Sundar
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[10] Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study
Cohen, Adam D.
Hari, Parameswaran
Htut, Myo
Berdeja, Jesus G.
Usmani, Saad Z.
Madduri, Deepu
Olyslager, Yunsi
Goldberg, Jenna D.
Schecter, Jordan M.
Jackson, Carolyn C.
Gries, Katharine S.
Fastenau, John M.
Valluri, Satish
Deraedt, William
Akram, Muhammad
Crawford, Rebecca
Morrison, Ross
Doward, Lynda
Morgan, Kate
ten Seldam, Silene
Jakubowiak, Andrzej
Jagannath, Sundar
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (01): : 68 - 77

← 1 2 3 4 5 →